ClinicalTrials.Veeva

Menu

Atrial Fibrillation in Beta-Thalassemia

U

University Hospital of Ferrara

Status

Enrolling

Conditions

Atrial Fibrillation
Thalassemia

Study type

Observational

Funder types

Other

Identifiers

NCT05508932
419/2022/Oss/AOUFe

Details and patient eligibility

About

The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.

Full description

Observational, retrospective and prospective, single-center study, which involves the collection of clinical, laboratory, electrocardiographic and imaging data of patients with major or intermediate thalassemia who have performed, from 2012 to 2022, or will perform in the next 10 years, a cardiological evaluation at the Cardiology Unit of the University Hospital of Ferrara. Patients will be divided into two groups: thalassemia patients with atrial fibrillation (paroxysmal, persistent or permanent) and thalassemia patients with no history of atrial fibrillation.

The objective of the study is to evaluate whether there is a different prevalence of the characteristics analyzed among these patient populations.

Enrollment

350 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Transfusion-dependent Beta-thalassemia;
  2. Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;
  3. Electrocardiogram performed;
  4. Echocardiogram performed.

Exclusion criteria

  1. Age <18 years;
  2. State Of pregnancy;
  3. Inability to give informed consent.

Trial design

350 participants in 1 patient group

Beta-thalassemia
Description:
Patients with Beta-thalassemia undergoing a cardiological evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems